Story · Medicine & Biotech
TGA greenlights second daily GLP-1 pill
2 outlets · first reported by AJP (Australian Journal of Pharmacy) on · latest · 1 hours of coverage
This content is for members only. Visit the site and log in/register to read. (The Medical Republic)
Coverage, in order
-
TGA registers new GLP-1 pill
The TGA has just registered Lilly’s GLP-1 pill, Foundayo (orforglipron), for the treatment of obesity and type 2 diabetes With stock to arrive in the coming days, Foundayo will be ...
-
TGA greenlights second daily GLP-1 pill
This content is for members only. Visit the site and log in/register to read.
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.